Insider · CIK 0001901198
Alon Ben-Noon
Files at NRSN (NeuroSense Therapeutics Ltd.). First filing Jun 17, 2026, latest Jun 17, 2026.
In brief
Alon Ben-Noon files SEC Form 4 as CEO at NRSN (NeuroSense Therapeutics Ltd.). Since Jun 17, 2026, Alon Ben-Noon has reported 1 open-market buy worth $200k and 0 open-market sells worth $0, the latest filed on Jun 17, 2026.
A track record needs three past buys with six months of prices behind them; Alon Ben-Noon has 0, so none is measured yet.
The newest scored trade: bought $200k of NRSN on Jun 16, 2026, filed Jun 17, 2026, scored 66 (notable). In the last 12 months: 1 buy worth $200k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NRSN: NeuroSense Therapeutics Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 66Notable | NeuroSense Therapeutics Ltd. | $200k 250,000 shares | +6% | +2% from low-71% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | NRSN NeuroSense Therapeutics Ltd. | POpen-market purchase Ordinary Shares | +250,000 | $0.80 | $200k | 4,534,233 | Jun 17, 2026 |
Questions about Alon Ben-Noon
Answered from the filings on this page, as of the latest one.
Is Alon Ben-Noon buying or selling?
In the last 12 months Alon Ben-Noon reported 1 open-market buy worth $200k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $200k of NRSN on Jun 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Alon Ben-Noon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alon Ben-Noon has 0.
Where does Alon Ben-Noon file Form 4?
Alon Ben-Noon has filed Form 4 at NRSN (NeuroSense Therapeutics Ltd.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.